| Jun 11 |
GSK, Pfizer to appeal Delaware ruling that allowed trials for thousands of Zantac cases
|
| Jun 11 |
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
|
| Jun 11 |
GSK Says Individual Plaintiff in Latest Zantac Case Dropped Claim
|
| Jun 8 |
GSK, SpringWorks end collaboration agreement
|
| Jun 8 |
GSK wins FDA nod to expand label for RSV vaccine
|
| Jun 7 |
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
|
| Jun 7 |
The City With the highest HIV/AIDS Rates in the US
|
| Jun 7 |
The total return for GSK (LON:GSK) investors has risen faster than earnings growth over the last year
|
| Jun 6 |
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
|
| Jun 6 |
GSK buys RNA therapeutics company for up to $50M
|
